If you’re under 60, have never had an ulcer, and are about to take ibuprofen for three days for back pain, you almost certainly don’t need omeprazole. If you’re 70, take a low-dose aspirin for your heart, or take an antidepressant, the answer changes completely, even though the course of treatment is exactly as long. The decision doesn’t depend on how many days you take the anti-inflammatory, or on whether it upsets you: it depends on your risk profile.
That distinction explains why pharmacies dispense so much omeprazole that wasn’t needed and, at the same time, why some people who did need it weren’t taking it.
The damage isn’t from contact, so eating doesn’t protect you
This is the misunderstanding underneath everything else. Non-steroidal anti-inflammatory drugs (NSAIDs) — ibuprofen, diclofenac, naproxen, dexketoprofen, acetylsalicylic acid — work by inhibiting the synthesis of prostaglandins. Those same prostaglandins are what maintain the layer of mucus and bicarbonate protecting the stomach lining. Block them and the protection drops from the inside, through the bloodstream, not because the tablet brushes against the stomach wall.
This is why the summary of product characteristics for ibuprofen notes that taking it with food delays the time to peak concentration (from around 2 hours on an empty stomach to around 3 hours with food) but does not change the total amount absorbed. Eating first makes it sit better if you have a sensitive stomach, and that is worth something; what it does not do is reduce the risk of an ulcer or a bleed. Those are two different things: discomfort and injury.
The uncomfortable consequence is that gastrointestinal bleeds and perforations from NSAIDs can appear at any point during treatment, with or without warning symptoms beforehand, and with or without any previous history. There is no tolerance phase you get past.
Who actually needs protection
The ibuprofen product information recommends concomitant treatment with a protective agent — a proton pump inhibitor or misoprostol — for the profiles below, and the omeprazole product information defines “at-risk patients” very specifically.
| Factor | Why it counts |
|---|---|
| Over 60 (the omeprazole criterion for prevention) | Older people have a higher incidence of gastrointestinal bleeding and perforation, which can be fatal |
| History of gastric or duodenal ulcer | Especially if it was complicated by bleeding or perforation |
| History of upper gastrointestinal bleeding | The risk stays elevated even years later |
| High doses or prolonged treatment | Risk rises as the NSAID dose rises |
| Low-dose acetylsalicylic acid (the “heart aspirin”) | Adds gastrointestinal risk even at a small dose |
| Oral anticoagulants such as warfarin or acenocoumarol | Increase the risk of bleeding |
| Oral corticosteroids | Raise the risk of ulcer and bleeding |
| SSRI antidepressants (fluoxetine, sertraline, escitalopram and others) | Increase the risk of gastrointestinal bleeding |
There are also two situations in which the NSAID simply should not be taken at all, protector or no protector: if you have had a gastrointestinal bleed or perforation related to previous NSAID treatment, or if you have active or recurrent peptic ulcer or gastrointestinal bleeding (two or more confirmed episodes). In those cases ibuprofen is contraindicated.
What counts as a real “protector”
Over the counter, the word “protector” gets applied to very different things, and not all of them protect.
- Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole). Yes. Omeprazole is authorised for the prevention of NSAID-associated gastric and duodenal ulcers in at-risk patients, at a dose of 20 mg once a day, in the morning, swallowing the capsule whole with half a glass of water.
- Misoprostol. Also yes, though it is little used today because of digestive tolerance and because it is contraindicated in pregnancy.
- Antacids (almagate, magaldrate, bicarbonate, aluminium and magnesium salts). No. They neutralise acid that is already there and relieve burning within minutes, but they do not prevent damage to the stomach lining. Taking the discomfort away is not the same as protecting you.
And one detail that gets overlooked: if you take clopidogrel, omeprazole is not the best choice. The product information advises against using the two together as a precaution, because omeprazole inhibits CYP2C19, the enzyme that activates clopidogrel. Raise it with your doctor or pharmacist, because there are alternatives.
Sometimes the answer isn’t to add, it’s to change
Before adding a second medicine, check whether the first one is the right one:
- Lowest effective dose, for the shortest possible time. That is the opening line of the ibuprofen dosage section, not a decorative suggestion.
- Paracetamol if there’s no inflammation. It isn’t an NSAID and doesn’t share this mechanism, so it doesn’t carry the same stomach risk. For pain with no inflammatory component it is usually enough.
- Topical route when the pain is local. With diclofenac gel, systemic absorption is roughly 6% of the dose compared with tablets. For tendinitis or a muscle knot, that difference matters a great deal.
- Never two NSAIDs at once. Combining ibuprofen with another NSAID, selective COX-2 inhibitors included, multiplies the risk of ulcer and bleeding without adding pain relief. And remember that acetylsalicylic acid is an NSAID too.
The protector isn’t harmless either
Taking omeprazole “just in case” for years has a bill of its own. The omeprazole product information warns of severe hypomagnesaemia on treatment lasting at least three months, of possible reduced vitamin B12 absorption with prolonged use, of a slight increase in the risk of hip, wrist and spine fracture especially at high doses for more than a year, and of a slight increase in the risk of Salmonella and Campylobacter gastrointestinal infections.
None of those risks justifies leaving someone who needs protection without it. They do justify not taking it out of habit when there is no indication.
The other half of the calculation: your heart
The stomach isn’t the only organ in play. The AEMPS restricted the use of high-dose ibuprofen (2,400 mg a day or more) because of its association with a small increase in the risk of arterial thrombotic events, comparable to that of the coxibs. At doses of 1,200 mg a day or less, epidemiological studies do not show that increase.
For diclofenac, the AEMPS estimated that you can expect 3 additional heart attacks per 1,000 patients with moderate cardiovascular risk treated for a year. Both are advised against if you have heart failure (NYHA classes II to IV), established ischaemic heart disease, peripheral arterial disease or cerebrovascular disease.
Put differently: the useful question isn’t only “do I need a protector?”, but “do I need this anti-inflammatory, at this dose, for this long?”.
When to see a doctor
Stop self-treating and seek medical attention if any of these appear:
- Vomiting blood or something that looks like coffee grounds (haematemesis), or black, sticky stools (melaena). These are signs of a gastrointestinal bleed and need urgent attention.
- Severe or sudden abdominal pain, particularly with dizziness, sweating or pallor.
- Any unusual abdominal symptom during the first weeks of treatment, especially if you are over 60 or have a history of digestive problems.
- Unintentional weight loss, repeated vomiting, difficulty swallowing: these are red flags that need investigating rather than masking with a protector.
- You need the anti-inflammatory for more than a few days in a row, or you go back to it every few weeks. Pain that keeps returning needs a diagnosis, not a dose.
- You are pregnant: NSAIDs are contraindicated in the third trimester and should be avoided from week 20 unless a doctor decides otherwise.
- You take anticoagulants, corticosteroids, SSRIs, methotrexate or lithium and have been recommended an anti-inflammatory without anyone reviewing the combination.
- Swollen ankles, a rise in blood pressure or breathlessness while taking the NSAID.
This information is general and does not replace assessment by a healthcare professional. Always read the leaflet that comes with your medicine and ask your pharmacist or doctor if anything is unclear. Sources: Summary of product characteristics, Ibuprofeno cinfa 600 mg film-coated tablets (CIMA, AEMPS, in Spanish) · Summary of product characteristics, Omeprazol cinfa 20 mg gastro-resistant capsules (CIMA, AEMPS, in Spanish) · Cardiovascular risk of high-dose ibuprofen or dexibuprofen: recommendations for use (AEMPS, in Spanish) · Diclofenac and cardiovascular risk: restrictions on use (AEMPS, in Spanish) · Summary of product characteristics, Voltaren Emulgel 11.6 mg/g gel (CIMA, AEMPS, in Spanish)